Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,841.00
Bid: 6,841.00
Ask: 6,842.00
Change: 47.00 (0.69%)
Spread: 1.00 (0.01%)
Open: 6,779.00
High: 6,873.00
Low: 6,761.00
Yest. Close: 6,794.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UPDATE 6-AbbVie cools on $55 bln Shire deal after U.S. tax changes

* AbbVie says it is reconsidering backing for deal * Shire shares down 23 percent * AbbVie board to meet on Oct. 20 * Deal was partly motivated by tax benefits * Shire urges AbbVie to stick to original plan (Adds analyst comment, Shire waiving 3-day notification, adds NE

15 Oct 14 21:18

UPDATE 6-AbbVie cools on $55 bln Shire deal after U.S. tax changes

* AbbVie says it is reconsidering backing for deal * Shire shares down 23 percent * AbbVie board to meet on Oct. 20 * Deal was partly motivated by tax benefits * Shire urges AbbVie to stick to original plan (Adds analyst comment, Shire waiving 3-day notification) B

15 Oct 14 21:11

3rd UPDATE: Shire Urges AbbVie To Proceed With Takeover, Notes Big Break Fee

15 Oct 14 17:48

UPDATE 5-AbbVie cools on $55 bln Shire deal after U.S. tax changes

* AbbVie says it is reconsidering backing for deal * Shire shares down 23 percent * AbbVie board to meet on Oct. 20 * Deal was partly motivated by tax benefits * Shire urges AbbVie to stick to original plan (Adds Breakingviews link) By Paul Sandle and Sarah Young</

15 Oct 14 17:02

UPDATE 4-AbbVie cools on $55 bln Shire deal after U.S. tax changes

* AbbVie says it is reconsidering backing for deal * Shire shares down 23 percent * AbbVie board to meet on Oct. 20 * Deal was partly motivated by tax benefits * Shire urges AbbVie to stick to original plan (Adds analyst comments, background on companies, updates shares)

15 Oct 14 16:41

MARKET COMMENT: FTSE Suffers Worst Fall Of 2014 As Fear Grips Market

15 Oct 14 16:33

Hedge funds bleed as AbbVie reconsiders Shire bid

* Hedge funds' hit as Shire slumps * AbbVie reconsiders its bid * John Paulson and Paul Singer have stakes in Shire By Sudip Kar-Gupta and Nishant Kumar LONDON, Oct 15 (Reuters) - Some of the world's best known hedge funds lost hundreds of millions of dollars in the value

15 Oct 14 15:51

BUZZ-Shire Plc: Back to where it all started as M&A premium vanishes

(Updated) ** Shire shares slammed after AbbVie says it is reconsidering inversion deal ** Sharpest one-day drop for Shire shares since February 2002, wipes off $14 billion in its market value and takes stock back where it was when news of AbbVie deal first broke in June ** Even

15 Oct 14 12:14

UPDATE 3-AbbVie cools on $55 bln Shire deal after U.S. tax changes

* AbbVie says it is reconsidering backing for deal * Shire shares down 27 percent * AbbVie board to meet on Oct. 20 * Deal was partly motivated by tax benefits * Shire urges AbbVie to stick to original plan (Adds further details) By Paul Sandle and Sarah Young <

15 Oct 14 11:48

UK WINNERS & LOSERS: Takeover News Sinks Shire But Drives CSR Higher

15 Oct 14 10:54

2nd UPDATE: Shire Urges AbbVie To Proceed With Takeover, Notes Big Break Fee

15 Oct 14 09:30

UPDATE 2-AbbVie cools on $55 bln Shire deal after U.S. tax changes

* AbbVie says reconsidering backing for deal * Shire shares down 27 percent * AbbVie board to meet on Oct. 20 * Deal was partly motivated by tax benefits * Shire urges AbbVie to stick to original plan (Adds background, reaction) By Paul Sandle and Sarah Young <p

15 Oct 14 08:15

BUZZ-Shire: back to where it all started as M&A premium vanishes

** Shire shares slammed after AbbVie says it is reconsidering deal. ** Sharpest one-day drop for Shire shares since Feb 2002 wipes off $14 bln in its market value and takes stock right back where it was when news of AbbVie deal first broke in June. ** Even after drop Shire is second-b

15 Oct 14 07:27

AbbVie To Reconsider Shareholder Recommendation On Inversion Deal For Shire

15 Oct 14 05:32

UPDATE 2-Ex-Merck analyst faces insider trading charges on merger tips

(Adds comment from Merck spokeswoman in paragraph eight, updates court appearance status in paragraph six) By Emily Flitter NEW YORK, Oct 14 (Reuters) - Federal prosecutors in New York charged a former Merck & Co Inc employee with conspiracy to commit fraud for tipping a contact about

14 Oct 14 20:52

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.